Megakaryocytes Harbour the Del(5q) Abnormality Despite Complete Clinical and Cytogenetic Remission Induced by Lenalidomide Treatment

British Journal of Haematology - United Kingdom
doi 10.1111/bjh.15094
Full Text
Abstract

Available in full text

Categories
Hematology
Date
Authors
Publisher

Wiley

Related search

Patients With Del(5q) MDS Who Fail to Achieve Sustained Erythroid or Cytogenetic Remission After Treatment With Lenalidomide Have an Increased Risk for Clonal Evolution and AML Progression

Annals of Hematology
MedicineHematology
2009English

Diagnosis of Del(5q) MDS, 14 Years After JAK-2 Positive PV Appearance: Complete Remission of Both Diseases With Lenalidomide Monotherapy

Mediterranean Journal of Hematology and Infectious Diseases
Infectious DiseasesHematology
2016English

FISH and SNP-A Karyotyping in Myelodysplastic Syndromes: Improving Cytogenetic Detection of Del(5q), Monosomy 7, Del(7q), Trisomy 8 and Del(20q)

Leukemia Research
Cancer ResearchOncologyHematology
2010English

Clonal Heterogeneity in the 5q- Syndrome: P53 Expressing Progenitors Prevail During Lenalidomide Treatment and Expand at Disease Progression

Haematologica
Hematology
2009English

Lenalidomide in 5q Minus Myelodysplastic Syndrome: How Long Is Enough?

Annals of Hematology
MedicineHematology
2009English

Unusual Clonal Evolution Involving 5q in a Case of Myelodysplastic Syndrome With Deletion 5q 31 Treated With Lenalidomide

Haematologica
Hematology
2008English

A Critical Role for Phosphatase Haplodeficiency in the Selective Suppression of Deletion 5q MDS by Lenalidomide

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2009English

Low-Dose Lenalidomide Plus Cytarabine Induce Complete Remission That Can Be Predicted by Genetic Profiling in Elderly Acute Myeloid Leukemia Patients

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2014English

Extended Survival and Reduced Risk of AML Progression in Erythroid-Responsive Lenalidomide-Treated Patients With Lower-Risk Del(5q) MDS

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy